Doxorubicin-loaded Drug-eluting beads Versus Conventional Transarterial Chemoembolization for Nonresectable Hepatocellular Carcinoma: Erratum (vol 21, pg 175, 2015)

被引：0
|
作者：
Arabi, M.
BenMousa, A.
Bzeizi, K.
Garad, F.
Ahmed, I
Al-Otaibi, M.
机构：
来源：
SAUDI JOURNAL OF GASTROENTEROLOGY | 2015年 / 21卷 / 04期
关键词：
D O I：
10.4103/1319-3767.161648
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：264 / 264
页数：1
相关论文
共 50 条
  • [21] Drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma: Current state of the art
    Antonio Facciorusso
    World Journal of Gastroenterology, 2018, (02) : 161 - 169
  • [22] Drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma: Current state of the art
    Facciorusso, Antonio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (02) : 161 - 169
  • [23] Cost-effectiveness analysis of drug-eluting beads and conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma
    Shao, Guoliang
    Wang, Jingwen
    Zhou, Xiaoying
    Sun, Guojun
    Dong, Zuojun
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [24] Acute Pancreatitis after Transarterial Chemoembolization of Hepatocellular Carcinoma with Drug-Eluting Beads
    Green, Tyler J.
    Gipson, Matthew G.
    SEMINARS IN INTERVENTIONAL RADIOLOGY, 2015, 32 (01) : 18 - 21
  • [25] A Lethal Complication after Transarterial Chemoembolization with Drug-Eluting Beads for Hepatocellular Carcinoma
    Toro, Adriana
    Bertino, Gaetano
    Arcerito, Maria Concetta
    Mannnino, Maurizio
    Ardiri, Annalisa
    Patane', Domenico
    Di Carlo, Isidoro
    CASE REPORTS IN SURGERY, 2015, 2015
  • [26] Conventional versus Doxorubicin-eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma
    Sacco, Rodolfo
    Bargellini, Irene
    Bertini, Marco
    Bozzi, Elena
    Romano, Antonio
    Petruzzi, Pasquale
    Tumino, Emanuele
    Ginanni, Barbara
    Federici, Graziana
    Cioni, Roberto
    Metrangolo, Salvatore
    Bertoni, Michele
    Bresci, Giampaolo
    Parisi, Giuseppe
    Altomare, Emanuele
    Capria, Alfonso
    Bartolozzi, Carlo
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2011, 22 (11) : 1545 - 1552
  • [27] Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Camrelizumab Compared With Conventional Transarterial Chemoembolization Plus Camrelizumab for Unresectable Hepatocellular Carcinoma
    Ren, Yanqiao
    Guo, Yusheng
    Chen, Lei
    Sun, Tao
    Zhang, Weihua
    Sun, Bo
    Zhu, Licheng
    Xiong, Fu
    Zheng, Chuansheng
    CANCER CONTROL, 2022, 29
  • [28] Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Camrelizumab Compared With Conventional Transarterial Chemoembolization Plus Camrelizumab for Unresectable Hepatocellular Carcinoma
    Ren, Yanqiao
    Guo, Yusheng
    Chen, Lei
    Sun, Tao
    Zhang, Weihua
    Sun, Bo
    Zhu, Licheng
    Xiong, Fu
    Zheng, Chuansheng
    CANCER CONTROL, 2022, 29
  • [29] Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Camrelizumab Compared With Conventional Transarterial Chemoembolization Plus Camrelizumab for Unresectable Hepatocellular Carcinoma
    Ren, Yanqiao
    Guo, Yusheng
    Chen, Lei
    Sun, Tao
    Zhang, Weihua
    Sun, Bo
    Zhu, Licheng
    Xiong, Fu
    Zheng, Chuansheng
    CANCER CONTROL, 2022, 29
  • [30] THE DIFFERENCE OF DOXORUBICIN AND CISPLATIN IN THE TRANSARTERIAL CHEMOEMBOLIZATION USING DRUG-ELUTING BEADS AGAINST INTERMEDIATE STAGE OF HEPATOCELLULAR CARCINOMA
    Asai, Akira
    Yasuoka, Hidetaka
    Ohama, Hideko
    Tsuchimoto, Yusuke
    Fukunishi, Shinya
    Higuchi, Kazuhide
    GASTROENTEROLOGY, 2019, 156 (06) : S1313 - S1314
12345